Source:http://linkedlifedata.com/resource/pubmed/id/10352273
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1999-6-16
|
pubmed:abstractText |
The costimulatory molecule CD28 has a restricted tissue distribution and is expressed on T cells and some plasmacytoma cells. Although CD28 is constitutively expressed, its expression is transiently down-regulated following T cell activation and declines progressively with in vitro senescence. In vivo, CD8+ T cells and, less frequently, CD4+ T cells may completely lose CD28 surface expression during chronic infections and with aging. This correlates with changes of nuclear protein-binding activities to two motifs, site alpha and beta, within the CD28 minimal promoter. Both alpha- and beta-bound complexes are found only in lymphoid tissues, in CD28+ T cells, and in some transformed B cells. These complexes are coordinately expressed except during replicative senescence, which is characterized by the down-modulation of site beta- but not site alpha-binding activities. In contrast, T cell activation induces a parallel decline in both site alpha- and beta-binding activities. CD4+ and CD8+ T cells differ in their beta-binding profiles, which may explain the more pronounced down-regulation of CD28 in senescent CD8+ T cells. In vivo expanded CD4+CD28null and CD8+CD28null T cells uniformly lack alpha- and beta-bound complexes, resembling the pattern seen in chronically activated cells and not of senescent cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6572-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10352273-Antibodies, Monoclonal,
pubmed-meshheading:10352273-Antigens, CD28,
pubmed-meshheading:10352273-Antigens, CD3,
pubmed-meshheading:10352273-Base Sequence,
pubmed-meshheading:10352273-Cell Aging,
pubmed-meshheading:10352273-Cell Division,
pubmed-meshheading:10352273-Cell Line,
pubmed-meshheading:10352273-Cell Line, Transformed,
pubmed-meshheading:10352273-Humans,
pubmed-meshheading:10352273-Lymphocyte Activation,
pubmed-meshheading:10352273-Lymphocyte Subsets,
pubmed-meshheading:10352273-Lymphoid Tissue,
pubmed-meshheading:10352273-Molecular Sequence Data,
pubmed-meshheading:10352273-T-Lymphocytes,
pubmed-meshheading:10352273-Transcription Factors,
pubmed-meshheading:10352273-Tumor Cells, Cultured
|
pubmed:year |
1999
|
pubmed:articleTitle |
Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence.
|
pubmed:affiliation |
Division of Rheumatology, Department of Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA. vallejo.abbe@mayo.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|